{"id":"W2264705762","doi":"10.1016/s1474-4422(16)00018-1","title":"Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Sphingosine-1-phosphate receptor; Placebo; Medicine; Sphingosine-1-phosphate; Internal medicine; Pharmacology; Receptor; Sphingosine; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002240892,0.002299319,0.00359732,0.0004835505,0.0004631699,0.001127013,0.001039707,0.003055436,0.006055885],"category_scores_gemma":[0.001886282,0.0007992195,0.002382917,0.0004262995,0.001632459,0.001461231,0.0004906925,0.003181659,0.001193424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000756815,"about_ca_system_score_gemma":0.0009083526,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007451164,"about_ca_topic_score_gemma":0.001244057,"domain_scores_codex":[0.9992,0.0004120719,0.00005450287,0.0001409533,0.00006026541,0.0001321224],"domain_scores_gemma":[0.999129,0.0002791295,0.0002158355,0.00007730129,0.00006118279,0.0002375318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9863454,0.002119901,0.0002823277,0.0005043745,0.0006097473,0.00002606535,0.00003595872,0.0001042541,0.002376461,0.00006093461,0.0003236576,0.007210917],"study_design_scores_gemma":[0.951709,0.04609075,0.0009606379,0.00002602527,0.0003978651,0.00002446268,0.00001674907,0.00009519793,0.0002634389,0.00008148506,0.000323148,0.00001124268],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868827,0.007969175,0.0003778377,0.0006773458,0.0004363213,0.001449836,0.0008172615,0.00007840399,0.001311051],"genre_scores_gemma":[0.9854215,0.00526528,0.001047459,0.00116744,0.0006566854,0.002343181,0.001327723,0.00002857159,0.00274219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006055885,"threshold_uncertainty_score":0.02025896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04882834581778473,"score_gpt":0.3012512679795377,"score_spread":0.252422922161753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}